Emerging Diseases News

Nearly 10% of patients with autoimmune rheumatic disease experience flares following COVID-19 vaccination, according to data published in Rheumatology.

BOSTON — Headache-related quality of life lagged clinical improvement in headaches for individuals with long COVID at 12 to 19 months, according to a poster from the American Academy of Neurology annual meeting.

“Network immunity” may have helped halt the global mpox outbreak, according to a study presented at the European Congress of Clinical Microbiology & Infectious Diseases.

Infection with SARS-CoV-2 increased the risk for long-term gastrointestinal problems within 1 year, including motility disorders, acute pancreatitis and liver disease, according to a study published in Nature Communications.

Sleep disturbance was common among patients hospitalized for COVID-19 and was associated with symptoms of long COVID, including breathlessness and reduced lung function, a study found.

HHS announced a $1.1 billion program to keep COVID-19 vaccines and treatments free for uninsured people once the public health and national emergencies end next month in the United States.

Mutations have allowed SARS-CoV-2 to evade previously effective treatments and preventives that have become a crucial tool for reducing severe COVID-19 and have made treating outpatients with COVID-19 more complicated.

Bivalent messenger RNA booster vaccinations were effective for preventing COVID-19 hospitalizations and deaths in older adults, according to data presented at the European Congress of Clinical Microbiology & Infectious Diseases.

The FDA on Tuesday authorized a second bivalent COVID-19 vaccine booster shot for adults aged 65 years or older and most immunocompromised patients, among other changes the agency said will simplify the U.S. vaccine schedule.

As the product of two hard-working academic physicians, I have never been without incredible examples of leaders in the field of medicine.